Weighted Average Number of Shares Outstanding, Basic of Regulus Therapeutics Inc. from Q3 2012 to Q1 2025

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Regulus Therapeutics Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and change rate from Q3 2012 to Q1 2025.
  • Regulus Therapeutics Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending 31 Mar 2025 was 66.2M shares, a 130% increase year-over-year.
  • Regulus Therapeutics Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2024 was 56.3M shares, a 197% increase from 2023.
  • Regulus Therapeutics Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 19M shares, a 24.2% increase from 2022.
  • Regulus Therapeutics Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 15.3M shares, a 78.1% increase from 2021.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Change (%)

Regulus Therapeutics Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 66.2M +37.4M +130% 01 Jan 2025 31 Mar 2025 10-Q 08 May 2025
Q4 2024 56.3M +37.4M +197% 01 Oct 2024 31 Dec 2024 10-K 13 Mar 2025
Q3 2024 65.5M +45.8M +234% 01 Jul 2024 30 Sep 2024 10-Q 07 Nov 2024
Q2 2024 64.5M +45.4M +237% 01 Apr 2024 30 Jun 2024 10-Q 08 Aug 2024
Q1 2024 28.7M +11.9M +70.7% 01 Jan 2024 31 Mar 2024 10-Q 08 May 2025
Q4 2023 19M +3.7M +24.2% 01 Oct 2023 31 Dec 2023 10-K 13 Mar 2025
Q3 2023 19.6M +4.66M +31.1% 01 Jul 2023 30 Sep 2023 10-Q 07 Nov 2024
Q2 2023 19.1M +4.49M +30.7% 01 Apr 2023 30 Jun 2023 10-Q 08 Aug 2024
Q1 2023 16.8M +2.25M +15.4% 01 Jan 2023 31 Mar 2023 10-Q 09 May 2024
Q4 2022 15.3M +6.69M +78.1% 01 Oct 2022 31 Dec 2022 10-K 21 Mar 2024
Q3 2022 15M +6.27M +72% 01 Jul 2022 30 Sep 2022 10-Q 09 Nov 2023
Q2 2022 14.6M +6.9M +89.4% 01 Apr 2022 30 Jun 2022 10-Q 08 Aug 2023
Q1 2022 14.6M -56.7M -79.5% 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023
Q4 2021 8.57M 01 Oct 2021 31 Dec 2021 10-K 23 Mar 2023
Q3 2021 8.7M -29.4M -77.2% 01 Jul 2021 30 Sep 2021 10-Q 14 Nov 2022
Q2 2021 7.72M -22.1M -74.1% 01 Apr 2021 30 Jun 2021 10-Q 11 Aug 2022
Q1 2021 71.3M 01 Jan 2021 31 Mar 2021 10-Q 13 May 2022
Q3 2020 38.1M 01 Jul 2020 30 Sep 2020 10-Q 12 Nov 2021
Q2 2020 29.8M 01 Apr 2020 30 Jun 2020 10-Q 10 Aug 2021
Q3 2015 52M +8.58M +19.8% 01 Jul 2015 30 Sep 2015 10-Q 06 Nov 2015
Q2 2015 51.1M +7.71M +17.8% 01 Apr 2015 30 Jun 2015 10-Q 05 Aug 2015
Q3 2014 43.4M +3.25M +8.1% 01 Jul 2014 30 Sep 2014 10-Q 06 Nov 2015
Q2 2014 43.4M +7.37M +20.5% 01 Apr 2014 30 Jun 2014 10-Q 05 Aug 2015
Q3 2013 40.2M -316M -88.7% 01 Jul 2013 30 Sep 2013 10-Q 06 Nov 2014
Q2 2013 36M 01 Apr 2013 30 Jun 2013 10-Q 07 Aug 2014
Q3 2012 356M 01 Jul 2012 30 Sep 2012 10-Q 14 Nov 2013

Regulus Therapeutics Inc. Annual Weighted Average Number of Shares Outstanding, Basic (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 56.3M +37.4M +197% 01 Jan 2024 31 Dec 2024 10-K 13 Mar 2025
2023 19M +3.7M +24.2% 01 Jan 2023 31 Dec 2023 10-K 13 Mar 2025
2022 15.3M +6.69M +78.1% 01 Jan 2022 31 Dec 2022 10-K 21 Mar 2024
2021 8.57M -26.4M -75.5% 01 Jan 2021 31 Dec 2021 10-K 23 Mar 2023
2020 35M 01 Jan 2020 31 Dec 2020 10-K 11 Mar 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.